<SEC-DOCUMENT>0001193125-18-277572-index.html : 20180919
<SEC-HEADER>0001193125-18-277572.hdr.sgml : 20180919
<ACCEPTANCE-DATETIME>20180919160216
ACCESSION NUMBER:		0001193125-18-277572
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20180919
DATE AS OF CHANGE:		20180919
EFFECTIVENESS DATE:		20180919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-227427
		FILM NUMBER:		181077788

	BUSINESS ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d619312ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
Document 1 - file: d619312ds3asr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d619312dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
Document 2 - file: d619312dex41.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d619312dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
Document 3 - file: d619312dex42.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d619312dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 4 - file: d619312dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>d619312dex121.htm
<DESCRIPTION>EX-12.1
<TEXT>
Document 5 - file: d619312dex121.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>d619312dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 6 - file: d619312dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>7
<FILENAME>d619312dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 7 - file: d619312dex232.htm

</DOCUMENT>
</SEC-DOCUMENT>